2096 — Simcere Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Simcere Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	PRESS	PRESS
Standards:	IFRS	IFRS	IFRS	—	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	902	3,274	2,183	2,623	2,018
Net Total Accounts Receivable
Net Total Receivables	1,363	1,915	2,436	2,345	2,645
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,898	6,467	4,980	5,458	5,639
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,870	2,128	1,931	2,139	2,170
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	6,767	10,943	10,161	10,789	10,854
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,429	3,497	3,064	2,967	2,686
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	5,286	5,642	3,724	3,657	3,631
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,480	5,302	6,437	7,132	7,223
Total Liabilities & Shareholders' Equity	6,767	10,943	10,161	10,789	10,854
Total Common Shares Outstanding